Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.
about
Anticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approachesObatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection.The role of HTS in drug discovery at the University of Michigan.Total synthesis of kingianin A.3-Substituted-N-(4-hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: structure-based design, synthesis, SAR, and biological evaluation.A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivoCrystallization and preliminary X-ray characterization of Epstein-Barr virus BHRF1 in complex with a benzoylurea peptidomimetic.IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndromeOptical properties of prodigiosin and obatoclax: action spectroscopy and theoretical calculations.Adaptive response, evidence of cross-resistance and its potential clinical useDARC: Mapping Surface Topography by Ray-Casting for Effective Virtual Screening at Protein Interaction Sites.BCL-2 inhibitors sensitize therapy-resistant chronic lymphocytic leukemia cells to VSV oncolysisOncogenic protein interfaces: small molecules, big challenges.Small molecule Mcl-1 inhibitors for the treatment of cancer.New dimension in therapeutic targeting of BCL-2 family proteins.miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapyThe safety of treatment options for elderly people with acute myeloid leukemia.uPAR peptide antagonist alters regulation of MAP kinases and Bcl-2 family members in favor of apoptosis in MDA-MB-231 cell lineCell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cellsMcl-1 inhibitors: a patent review.AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis.Treatment of Elderly Patients With Acute Myeloid Leukemia.Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.Molecular docking studies of bioactive compounds from Annona muricata Linn as potential inhibitors for Bcl-2, Bcl-w and Mcl-1 antiapoptotic proteins.Genes and pathways associated with the occurrence of malignancy in benign lymphoepithelial lesions.Development of an efficient route toward meiogynin A-inspired dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins.Quercetin induces apoptosis and enhances 5-FU therapeutic efficacy in hepatocellular carcinoma.miR-371-5p suppresses the proliferative and migratory capacity of human nasopharyngeal carcinoma by targeting BCL2.Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening
P2860
Q28540187-F123B913-861A-4DAE-8EDA-4A227E748B12Q30448355-EC149BB2-0105-44A9-A931-2893FB5DC435Q31147980-7037086B-E966-49B9-BFE5-FE537A5A3773Q33625206-CED63806-EE24-4EA4-8704-2E352AD816A0Q33662495-3AF3CFDD-44B9-40BC-A049-76F9C5451E2DQ34241381-A790CC41-2A4B-4489-8B6D-069BFC4A58A0Q34494820-31D2EC3A-541A-4031-A30E-F92EDAF4ED57Q35130847-E4727842-DA0B-4EB0-B181-14D03D0F1FDFQ35676827-56934599-170A-41FF-923E-56E1AEEDDD3AQ36321702-F8AC4B87-934E-4F4E-86BC-CB3D58AC5A42Q36447801-C2B7D9B2-8699-451C-89C4-3ADE002A251FQ36984500-5AE1B255-7448-4161-BFA5-7692DD28B31FQ38195457-4257CFA1-37C8-45D2-84F2-187B28214A0BQ38244767-618AC055-4925-4C6F-9902-10A4AF979FB2Q38477617-C8961279-69D9-483A-B990-C3ED476861F9Q38707925-3D42B8FB-C014-44C6-A9A4-16C73716AA98Q38760822-75457F86-AEDD-45AA-8097-ACEC73D53B6BQ38817198-A1B51E33-70AC-4F02-97BE-0E48379FB1BFQ38850608-07DC7EDF-C584-4E56-ACBA-19DFD3D5B719Q38981785-E73AD76E-87B8-40F3-A626-4EA2536673AAQ39058012-F4F3419D-9241-46E0-B72E-98B16BDF9B00Q39112940-5F534E40-5BCF-40CB-9BC6-C01670F343A6Q39180901-703FBB5B-19FC-45CA-97D4-159F2983C988Q42051478-4F093B07-969E-484D-B3A2-AC6F755605A0Q47284705-5FEC2A63-875A-4C56-919C-0B94BA844ED3Q47569368-E408BE00-CB59-4067-8627-79F0419738FBQ50988795-E7E7601F-8A06-411B-A1A2-A791791CBCCDQ52899086-9463FC0F-24AB-4FE4-B139-CF8E2DDE32A8Q55136088-9737FAC7-A133-4B19-A177-A1A766389E5EQ56811078-63625FE2-D852-4ECF-A60C-74DB4A02F8F0
P2860
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.
@ast
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.
@en
type
label
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.
@ast
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.
@en
prefLabel
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.
@ast
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.
@en
P2093
P2860
P1476
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.
@en
P2093
Chenzhong Liao
Naval Bajwa
Zaneta Nikolovska-Coleska
P2860
P356
10.1517/13543776.2012.644274
P407
P577
2011-12-23T00:00:00Z